Literature DB >> 31791945

In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B.

Yongqin Wu1,2, Marissa Totten2, Warda Memon3, Chunmei Ying1, Sean X Zhang4,3.   

Abstract

Entities:  

Keywords:  Candida auriszzm321990; antifungal activity; antifungal agents; antifungal susceptibility testing; miltefosine; synergy

Mesh：

Substances：

Year:  2020        PMID： 31791945      PMCID： PMC6985732          DOI： 10.1128/AAC.02063-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  18 in total

1.  Synergy, antagonism, and what the chequerboard puts between them.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

Review 2.  Candida auris and multidrug resistance: Defining the new normal.

Authors:  Shawn R Lockhart
Journal:  Fungal Genet Biol       Date:  2019-06-20       Impact factor: 3.495

3.  In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.

Authors:  Fabrice Compain; Françoise Botterel; Emilie Sitterlé; André Paugam; Marie-Elisabeth Bougnoux; Eric Dannaoui
Journal:  J Med Microbiol       Date:  2015-01-16       Impact factor: 2.472

4.  Candidemia caused by amphotericin B and fluconazole resistant Candida auris.

Authors:  S Sarma; N Kumar; S Sharma; D Govil; T Ali; Y Mehta; A Rattan
Journal:  Indian J Med Microbiol       Date:  2013 Jan-Mar       Impact factor: 0.985

5.  In vitro combination of voriconazole and miltefosine against clinically relevant molds.

Authors:  S Imbert; M Palous; I Meyer; E Dannaoui; D Mazier; A Datry; A Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2014-09-08       Impact factor: 5.191

6.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.

Authors:  Shawn R Lockhart; Kizee A Etienne; Snigdha Vallabhaneni; Joveria Farooqi; Anuradha Chowdhary; Nelesh P Govender; Arnaldo Lopes Colombo; Belinda Calvo; Christina A Cuomo; Christopher A Desjardins; Elizabeth L Berkow; Mariana Castanheira; Rindidzani E Magobo; Kauser Jabeen; Rana J Asghar; Jacques F Meis; Brendan Jackson; Tom Chiller; Anastasia P Litvintseva
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

7.  Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; William R Kirkpatrick; Tania C Sorrell; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2012-11-19       Impact factor: 5.191

8.  A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.

Authors:  Anuradha Chowdhary; Anupam Prakash; Cheshta Sharma; Milena Kordalewska; Anil Kumar; Smita Sarma; Bansidhar Tarai; Ashutosh Singh; Gargi Upadhyaya; Shalini Upadhyay; Priyanka Yadav; Pradeep K Singh; Vikas Khillan; Neelam Sachdeva; David S Perlin; Jacques F Meis
Journal:  J Antimicrob Chemother       Date:  2018-04-01       Impact factor: 5.790

9.  Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris.

Authors:  Johanna Rhodes; Alireza Abdolrasouli; Rhys A Farrer; Christina A Cuomo; David M Aanensen; Darius Armstrong-James; Matthew C Fisher; Silke Schelenz
Journal:  Emerg Microbes Infect       Date:  2018-03-29       Impact factor: 7.163

10.  Sentinel Case of Candida auris in the Western United States Following Prolonged Occult Colonization in a Returned Traveler from India.

Authors:  Michael H Woodworth; David Dynerman; Emily D Crawford; Sarah B Doernberg; Lynn Ramirez-Avila; Paula Hayakawa Serpa; Amy Nichols; Lucy M Li; Amy Lyden; Cristina M Tato; Steve Miller; Joseph L Derisi; Charles Langelier
Journal:  Microb Drug Resist       Date:  2019-06       Impact factor: 3.431
View more
  7 in total

Review 1.  Emerging and future strategies in the management of recalcitrant Candida auris.

Authors:  Nihal Bandara; Lakshman Samaranayake
Journal:  Med Mycol       Date:  2022-03-17       Impact factor: 4.076

2.  Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action.

Authors:  Martin Hoenigl; Rosanne Sprute; Amir Arastehfar; John R Perfect; Cornelia Lass-Flörl; Romuald Bellmann; Juergen Prattes; George R Thompson; Nathan P Wiederhold; Mohanad M Al Obaidi; Birgit Willinger; Maiken C Arendrup; Philipp Koehler; Matteo Oliverio; Matthias Egger; Ilan S Schwartz; Oliver A Cornely; Peter G Pappas; Robert Krause
Journal:  Expert Opin Investig Drugs       Date:  2022-06-15       Impact factor: 6.498

3.  In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.

Authors:  Fruzsina Nagy; Zoltán Tóth; Fanni Nyikos; Lajos Forgács; Ágnes Jakab; Andrew M Borman; László Majoros; Renátó Kovács
Journal:  Med Mycol       Date:  2021-10-04       Impact factor: 4.076

4.  Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.

Authors:  Michael A Pfaller; Shawn A Messer; Lalitagauri M Deshpande; Paul R Rhomberg; Eric A Utt; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 5.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813

Review 6.  Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris.

Authors:  Muriel Billamboz; Zeeshan Fatima; Saif Hameed; Samir Jawhara
Journal:  Microorganisms       Date:  2021-03-18

7.  Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.

Authors:  Thaila Fernanda Dos Reis; Maria Augusta Crivelente Horta; Ana Cristina Colabardini; Caroline Mota Fernandes; Lilian Pereira Silva; Rafael Wesley Bastos; Maria Vitória de Lazari Fonseca; Fang Wang; Celso Martins; Márcio L Rodrigues; Cristina Silva Pereira; Maurizio Del Poeta; Koon Ho Wong; Gustavo H Goldman
Journal:  mBio       Date:  2021-08-10       Impact factor: 7.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.